Siklu Raises $19 Million for Cheaper Wireless Bandwidth

Israeli startup Siklu Wireless Communications has raised a series B round of $19 million led by new investors Amiti Ventures, Qualcomm Ventures and joined by all existing investors: DFJ- Tamir Fishman Ventures, Evergreen Venture Partners and Argonaut Private Equity. Another strategic investor (CVC) joined the round but remained undisclosed. Siklu Wireless Communications has previously raised $12 million in 2008, bringing the funding to date to $31 million.

Special: Top 50 Israeli Startups for 2011

For the third consecutive year, Israeli financial newspaper Calcalist put together a list of the top 50 startups in Israel (in Hebrew). VC Cafe took note to bring you the full list of top 50 Israeli startups in English: PowerMat, Broadlight, Conduit, PrimeSense, Objet, Kenshoo, Imperva, Anobit, DoubleVerify, Wix, SuperDerivatives, AeroScout, Siano, Waze, TaKaDu, ExLibris, SolarEdge, Adsmarket, (Matomy), dbMotion, RADWIN, cVidya, Boxee, N—trig, Cotendo, Varonis, Kontera, Outbrain, RedBend, Mobixell, Celeno, AMIMON, Pontis, Gigya, Clarizen, Mobileye, Celtro, Altair, Amobee, WhiteSmoke, Cyber—Ark, OpTier, Wanova, ConteXtream, eXelate, Peer39, Netformx, Tradonomi (eToro), Surf, Zend, Soluto

DFJ Invests $7 Million in Stealth Startup Zon networks

  Ofer Vilenski & Derry Shribman, the two entrepreneurs who previously sold Jungo to NDS Group for $108 million in 2006 go at it again.  Founded only 6 months ago, Zon networks (temporary name) prefers to completely fly under the radar even after announcing the $7 million round led by Draper Fischer Jurvetson (original backer of Hotmail and Skype), Israeli VC funds Tamir Fishman Venture Capital …

The Golden Age? Israeli Startups Experience Funding Streak (Part I)

Since I started following the Israeli market in 2005, it’s not often that I’ve seen so many Israeli startups raise money in such a short period of time. Capital raising is seen across the board in Telecommunications, Cleantech, Internet, Consumer Electronics and Biotech in the last couple of weeks. Is this the Golden Age of …

Exit mobile version